Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06917495 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To evaluate the non-inferiority in efficacy between the rifapentine- and moxifloxacin-containing short-course regimens (with rifampicin replaced by rifapentine and ethambutol replaced by moxifloxacin, while isoniazid and pyrazinamide remaining the same as the empirical regimen) and the empirical long-course regimen, so as to determine whether it is possible to shorten the treatment duration to 26 weeks for patients with mild spinal tuberculosis.
Trial Details
NCT Number NCT06917495
Lead Sponsor Shandong University
Collaborators: Shandong Public Health Clinical Center
Conditions
(from sponsor)		 Mild Spinal Tuberculosis
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov